Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Experimental topical dental formulations developed by GSK for the prevention and treatment of dental caries. These formulations combine fluoride (typically 1150 ppm as sodium fluoride) with varying concentrations of phytate (0.425% or 0.85%). Fluoride acts as a primary remineralizing agent by promoting the formation of fluorapatite on tooth enamel and inhibiting demineralization. Phytate is included as a surface-active agent intended to enhance extrinsic stain removal and prevention. Clinical research using in situ caries models in adults has demonstrated that the addition of phytate does not impair the remineralization efficacy of fluoride. Some experimental variants also incorporate zinc chloride and sodium citrate for additional oral health benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phytate + fluoride.